Loomis, Sayles & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61M | Buy |
|
|||||
|
2025
Q1 | $5.76M | Sell |
|
|||||
|
2024
Q4 | $13.9M | Sell |
|
|||||
|
2024
Q3 | $14.4M | Buy |
|
|||||
|
2024
Q2 | $8.93M | Buy |
|
|||||
|
2024
Q1 | $7.96M | Buy |
|
|||||
|
2023
Q4 | $5.44M | Buy |
|
|||||
|
2023
Q3 | $3.28M | Sell |
|
|||||
|
2023
Q2 | $3.94M | Buy |
|
|||||
|
2023
Q1 | $3.23M | Sell |
|
|||||
|
2022
Q4 | $3.94M | Buy |
|
|||||
|
2022
Q3 | $3.52M | Sell |
|
|||||
|
2022
Q2 | $19.5M | Sell |
|
|||||
|
2022
Q1 | $29.9M | Sell |
|
|||||
|
2021
Q4 | $36.2M | Buy |
|
|||||
|
2021
Q3 | $33.5M | Sell |
|
|||||
|
2021
Q2 | $125M | Sell |
|
|||||
|
2021
Q1 | $334M | Sell |
|
|||||
|
2020
Q4 | $711M | Sell |
|
|||||
|
2020
Q3 | $807M | Sell |
|
|||||
|
2020
Q2 | $798M | Sell |
|
|||||
|
2020
Q1 | $757M | Sell |
|
|||||
|
2019
Q4 | $883M | Sell |
|
|||||
|
2019
Q3 | $727M | Buy |
|
|||||
|
2019
Q2 | $649M | Buy |
|
|||||
|
2019
Q1 | $595M | Buy |
|
|||||
|
2018
Q4 | $563M | Buy |
|
|||||
|
2018
Q3 | $619M | Sell |
|
|||||
|
2018
Q2 | $742M | Sell |
|
|||||
|
2018
Q1 | $852M | Sell |
|
|||||
|
2017
Q4 | $828M | Sell |
|
|||||
|
2017
Q3 | $866M | Buy |
|
|||||
|
2017
Q2 | $737M | Buy |
|
|||||
|
2017
Q1 | $715M | Sell |
|
|||||
|
2016
Q4 | $798M | Buy |
|
|||||
|
2016
Q3 | $734M | Buy |
|
|||||
|
2016
Q2 | $982M | Sell |
|
|||||
|
2016
Q1 | $861M | Sell |
|
|||||
|
2015
Q4 | $927M | Buy |
|
|||||
|
2015
Q3 | $794M | Buy |
|
|||||
|
2015
Q2 | $892M | Buy |
|
|||||
|
2015
Q1 | $849M | Sell |
|
|||||
|
2014
Q4 | $830M | Sell |
|
|||||
|
2014
Q3 | $765M | Sell |
|
|||||
|
2014
Q2 | $728M | Buy |
|
|||||
|
2014
Q1 | $763M | Buy |
|
|||||
|
2013
Q4 | $779M | Sell |
|
|||||
|
2013
Q3 | $686M | Sell |
|
|||||
|
2013
Q2 | $662K | Buy |
|